Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

SNSS $0.65 0.1439 +28.44%
CYTK $11.12 1.1700 +11.76%
SPHS $5.86 0.4600 +8.52%
BDSI $2.55 0.2000 +8.51%
NKTR $17.29 1.1900 +7.39%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PVCT $0.29 -0.0200 -6.45%
TGTX $5.91 -0.4000 -6.34%
VSTM $1.40 -0.0800 -5.41%
GALE $0.44 -0.0254 -5.40%
NLNK $10.58 -0.5300 -4.77%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

I'm an Immigrant and a Muslim. And I'm Here to Cure Cancer

(STAT/First Opinion) July 28, 2016 - Over the next 10 years, the number of new cancer cases in the United States will increase by 42 percent. During the same period, the number of oncologists will increase by only 28 percent. Many of the new doctors will be immigrants.
read article 



The Leukemia & Lymphoma Society and PlatformQ Health Partner to Host Inaugural Program on CancerCoachLive, a New Online Patient Education Platform

(PRWeb) July 28, 2016 - First CancerCoachLive event on August 4th with focus on Non-Hodgkin Lymphomas.
read article 



Ridgeview and Minnesota Oncology Will Launch Joint Cancer Care Venture

(Minneapolis/St. Paul Business Journal) July 26, 2016 - Ridgeview Medical Center and physician group Minnesota Oncology will consolidate some of their cancer-care clinics through a joint venture launching Sept. 1.
read article 



Merck and AmoyDx Collaborate to Bring Liquid Biopsy RAS Biomarker Testing to China

(Yahoo! Finance) July 28, 2016 - Merck, a leading science and technology company, today announced that it has signed a new collaboration agreement with Xiamen based Amoy Diagnostics Co., Ltd. (AmoyDx) for the development and commercialization of a new liquid biopsy RAS biomarker test for patients with metastatic colorectal cancer (mCRC).
read article 



New Cancer-Focused Biotech Forty Seven Inc. Selects Medidata to Accelerate Novel Immuno-Oncology R&D

(Medidata) July 28, 2016 - Stanford University startup leverages Medidata's cloud technology to tackle cancers with limited treatment options.
read corporate press release 



Kite Pharma Announces Exclusive License with the National Institutes of Health for Fully Human Anti-CD19 Chimeric Antigen Receptor (CAR) Product Candidate to Treat B-Cell Malignancies

(NASDAQ) July 27, 2016 - Kite Pharma, Inc. today announced that the Company has entered into an exclusive, worldwide license with the National Institutes of Health (NIH) for intellectual property related to a fully human anti-CD19 chimeric antigen receptor-based product candidate directed against B-cell malignancies.
read article 



Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel Oncolytic Virus Technology

(4-traders) July 28, 2016 - Companies plan to advance Western Oncolytics' lead preclinical therapy into human testing; potential combination of WO-12 with Pfizer's oncology pipeline could enhance therapeutic benefit in patients.
read article 



Pfizer Cleared to Buy Nanotech Drug Firm Bind Therapeutics

(Morningstar/Dow Jones Newswires) July 27, 2016 - The sale price means the business, which develops drug treatments that use nanoparticles to treat cancer, will continue in Pfizer's hands.
read article 



Evolving Roles: Review Article Suggests that Radiologists Need to Solidify Their Position on Cancer Teams

(American Roentgen Ray Society) July 26, 2016 - Given the anticipated increase in cancer imaging over the next decade, radiologists need to solidify their position as central members of the cancer team by identifying toxicity early and understanding the implications of their findings.
read press release 



NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma

(Novocure) July 26, 2016 - Novocure announced today that the National Comprehensive Cancer Network (NCCN) has recommended Optune as a standard treatment option for newly diagnosed glioblastoma (GBM) in its Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Central Nervous System Cancers.
read corporate press release 



Updated Testing Guidelines Make More Women Eligible for Herceptin, yet Benefit Uncertain

(Mayo Clinic) July 27, 2016 - Mayo Clinic researchers found that the number of HER2-positive breast cancers doubled after testing guidelines were changed by the American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) in 2013.
read article 



Genelux Initiates Two Clinical Trials of GL-ONC1 in Ovarian Cancer and Solid Organ Cancers with Leading Oncology Institutions

(Yahoo! Finance) July 28, 2016 - Genelux Corporation today announced that it has initiated two new Phase 1b clinical trials of its lead oncolytic virotherapy GL-ONC1 with leading oncology institutions, Florida Hospital Cancer Institute (FHCI) in Orlando and Moores Cancer Center at UC San Diego Health.
read article 



Early Detection of Leukaemia Patients' Resistance to Therapy

(University of Adelaide [South Australia]) July 28, 2016 - Adelaide researchers have made a world-first breakthrough in the early detection of patients' resistance to a common treatment for chronic myeloid leukaemia, offering some hope that the patients' treatment could be changed sooner to improve their chances of survival.
read press release 



Fox Chase Cancer Center Researchers Identify Mechanism for Drug Resistance in Ovarian Cancer

(Fox Chase) July 27, 2016 - Researchers at Fox Chase Cancer Center have found that BET inhibitors, drugs that block the function of BET bromodomain proteins in cancer cells, may have limited success as single agents in ovarian cancer due to reprogramming of the protein kinome, leading to drug resistance.
read press release 



Study Finds Tests, Scans To Treat Ovarian Cancer Not Always Necessary

(Health Imaging) July 26, 2016 - While the costs of cancer continue to rise, examining which treatments are worth the time and money is increasingly more important to physicians looking to find the most affordable and effective treatments.
read article 



Combining Ipilimumab With Local Treatments Improved Survival for Patients With Melanoma

(AACR) July 27, 2016 - Among patients with melanoma, those who received both ipilimumab (Yervoy) and local peripheral treatments such as radiotherapy or electrochemotherapy had significantly prolonged overall survival compared with those who received only ipilimumab, according to a retrospective clinical study.
read press release 



Earliest Human Cancer Found in 1.7-Million-Year-Old Bone

(National Geographic) July 28, 2016 - The ancient toe from a human relative in South Africa could have important implications for modern medical research.
read article 



Half of Dermatologists Say They Weren't Trained to Spot Cancer on Black Skin

(New York Magazine/Science of Us) July 27, 2016 - There are so many damning statistics in a piece published this week by STAT, the health and science news site launched last fall by the Boston Globe, about racial disparities in health care.
read article 



CMS Releases Star Ratings For Hospitals

(ModernHealthcare.com) July 27, 2016 - The CMS published the much-anticipated Overall Hospital Quality Star Ratings on Wednesday after industry stakeholders and Congress pressured the agency to continue to delay their release.
read article (free registration required) 



Eli Lilly CEO John Lechleiter to Retire, David Ricks to Replace Him

(NASDAQ/Dow Jones Business News) July 27, 2016 - Eli Lilly & Co. Chief Executive John C. Lechleiter will retire at the end of the year, the company said Wednesday, capping nearly four decades at the pharmaceutical manufacturer and an eight-year tenure at its helm.
read article 



GSK Chases Next Biotech Asthma Drug With $230M J&J Deal

(Reuters) July 27, 2016 - GlaxoSmithKline has bought global rights to an experimental drug from Johnson & Johnson for up to 175 million pounds ($230 million), raising its bet on a new generation of biotech medicines for severe asthma.
read article 



Alzheimer's Maverick TauRx Tries To Weave Success From Failed Trial

(Forbes) July 27, 2016 - The company says that in 15% of the patients in the study who did not receive other Alzheimer's drugs there was a dramatic benefit. Others are skeptical.
read article 



Want to Enroll In A Clinical Trial? NIH Database Is Huge — But Lacks A Few Key Details

(Washington Post) July 26, 2016 - Critics fault ClinicalTrials.gov for not vetting studies or listing charges patients may face.
read article (free registration required) 



Senator: Is Medicare Drug Plan Vulnerable To Exploitation?

(U.S. News & World Report/Associated Press) July 27, 2016 - A senior senator is examining whether Medicare's prescription drug benefit is vulnerable to manipulation by pharmaceutical companies that set very high prices for medications.
read article 



Cancer Research Institute to Honor Three Scientists for Outstanding Contributions to Cancer Immunotherapy Research

(Cancer Research Institute) July 26, 2016 – The Cancer Research Institute (CRI) will bestow its highest honors on three scientists who have made seminal contributions to the fields of immunology and cancer immunology at its 30th Annual Awards gala.
read press release